Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients. [electronic resource]
Producer: 20150616Description: 749-58 p. digitalISSN:- 1432-1335
- Aged
- Bone Density Conservation Agents -- adverse effects
- Breast Neoplasms -- drug therapy
- Diphosphonates -- adverse effects
- Disease-Free Survival
- Female
- Germany
- Hematologic Neoplasms -- drug therapy
- Humans
- Ibandronic Acid
- Imidazoles -- adverse effects
- Jaw Diseases -- chemically induced
- Kaplan-Meier Estimate
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Neoplasms -- drug therapy
- Osteonecrosis -- chemically induced
- Pamidronate
- Prostatic Neoplasms -- drug therapy
- Registries -- statistics & numerical data
- Risk Factors
- Sex Factors
- Time Factors
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.